Oneview Healthcare (ASX:ONE) Moat Score: 0/10 (As of Jun. 29, 2026)


ASX:ONE Oneview Healthcare PLC ASX:ONE
45 GF Score
Price A$0.15
GF Value A$0.33
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Oneview Healthcare Moat Score?

Oneview Healthcare has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Oneview Healthcare has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Oneview Healthcare might have No Moat - No discernible moat.

Oneview Healthcare  (ASX:ONE) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Oneview Healthcare Moat Score Related Terms

ASX:ONE
45GF Score
Oneview Healthcare PLC ASX:ONE
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?

Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued. The current stock price of A$0.15 is trading 56.1% below its estimated GF Value™ of A$0.33. GuruFocus considers Oneview Healthcare to be Possible Value Trap.

Key valuation signals for ASX:ONE:

  • Moat Score: 0
  • GF Value™: A$0.33 vs. price of A$0.15 (56.1% below fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oneview Healthcare Business Description

Address Temple Road, 2nd Floor, Avoca Court, Blackrock Co, Dublin, IRL, A94 R7W3
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
45GF Score

Get the complete analysis for ASX:ONE

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.15
Price
A$0.33
GF Value